Insider Buying: 4basebio (LON:4BB) Insider Buys 2,650 Shares of Stock

4basebio PLC (LON:4BB) insider Amy Walker purchased 2,650 shares of the firm’s stock in a transaction that occurred on Friday, February 13th. The stock was purchased at an average price of GBX 586 per share, with a total value of £15,529.

4basebio Stock Performance

Shares of LON:4BB opened at GBX 569.75 on Monday. 4basebio PLC has a 52 week low of GBX 520 and a 52 week high of GBX 1,220. The company’s 50 day moving average is GBX 600.82 and its two-hundred day moving average is GBX 730.53. The company has a market cap of £88.23 million, a PE ratio of -5.76 and a beta of 1.09. The company has a current ratio of 2.73, a quick ratio of 3.52 and a debt-to-equity ratio of 201.47.

4basebio Company Profile

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.